HtrA2 Independently Predicts Poor Prognosis and Correlates with Immune Cell Infiltration in Hepatocellular Carcinoma

High-temperature requirement protein A2 (HtrA2), a mitochondrial protein, is related to apoptosis regulation. However, the role of HtrA2 in hepatocellular carcinoma (HCC) remains unclear. In the present study, we explored the prognostic value and expression pattern of HtrA2 in HCC and confirmed its independent value for predicting outcomes via Cox analyses. LinkedOmics and GEPIA2 were used to construct the coexpression and functional networks of HtrA2. Additionally, the data obtained from TCGA was analyzed to investigate the relationship between the infiltration of immune cells and HtrA2 mRNA expression. Finally, the expression pattern of HtrA2 in HCC was confirmed by wet-lab experiments. The results showed high HtrA2 expression (P < 0.001) presented in tumor tissues in TCGA-HCC. Moreover, high HtrA2 expression was confirmed to be associated with poor HCC patient survival (P < 0.05). HtrA2 has also been recognized as an essential risk factor for overall survival (P=0.01, HR = 1.654, 95% CI 1.128–2.425), disease-specific survival (P=0.004, HR = 2.204, 95% CI 1.294–3.753), and progression-free interval (P=0.007, HR = 1.637, 95% CI 1.145–2.341) of HCC. HCC patients with low HtrA2 methylation had worse overall survival than patients with high methylation (P=0.0019). Functional network analysis suggests that HtrA2 regulates mitochondrial homeostasis through pathways involving multiple microRNAs and transcription factors in HCC. In addition, HtrA2 expression correlated with infiltrating levels of multiple immune cell populations. At last, increased expression of HtrA2 in HCC was confirmed using wet-lab experiments. Our study provides evidence that the upregulation of HtrA2 in HCC is an independent predictor of prognosis. Our results provide the foundation for further study on the roles of HtrA2 in HCC tumorigenesis.

[1]  Chuan-Yan Zhu,et al.  The circular RNA hsa_circ_0001394 promotes hepatocellular carcinoma progression by targeting the miR-527/UBE2A axis , 2022, Cell death discovery.

[2]  Yuxiu Huang,et al.  DLC1 Is a Prognosis-Related Biomarker Correlated With Tumor Microenvironment Remodeling in Endometrial Carcinoma , 2022, Frontiers in Oncology.

[3]  Wenling Zhang,et al.  mRNA microarray profiling identifies a novel circulating HTRA2 for detection of gastric cancer , 2021, Journal of clinical laboratory analysis.

[4]  L. Xiao,et al.  Delivery of miR-26a Using an Exosomes-Based Nanosystem Inhibited Proliferation of Hepatocellular Carcinoma , 2021, Frontiers in Molecular Biosciences.

[5]  L. Kay,et al.  Dissecting the role of interprotomer cooperativity in the activation of oligomeric high-temperature requirement A2 protein , 2021, Proceedings of the National Academy of Sciences.

[6]  Bing Chen,et al.  miR-26a enhances colorectal cancer cell growth by targeting RREB1 deacetylation to activate AKT-mediated glycolysis. , 2021, Cancer letters.

[7]  Qingfeng Ni,et al.  Transcription factor PAX4 facilitates gastric cancer progression through interacting with miR-27b-3p/Grb2 axis , 2021, Aging.

[8]  Y. Rikihisa,et al.  An intracellular nanobody targeting T4SS effector inhibits Ehrlichia infection , 2021, Proceedings of the National Academy of Sciences.

[9]  P. Yang,et al.  miR-186 Inhibits Liver Cancer Stem Cells Expansion via Targeting PTPN11 , 2021, Frontiers in Oncology.

[10]  Xiaohan Cui,et al.  LncRNA loc339803 acts as CeRNA of miR-30a-5p to promote the migration and invasion of hepatocellular carcinoma cells , 2021, Journal of Cancer.

[11]  Seong-Tshool Hong,et al.  Identification and Characterization of Plasmin-Independent Thrombolytic Enzymes , 2020, Circulation research.

[12]  Chao Ma,et al.  Independent prognostic implications of RRM2 in lung adenocarcinoma , 2020, Journal of Cancer.

[13]  Peng Zhou,et al.  SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation , 2020, Signal Transduction and Targeted Therapy.

[14]  Jing Luo,et al.  The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma , 2020, Cell Death & Disease.

[15]  Richard G. Lee,et al.  RIPK1 gene variants associate with obesity in humans and can be therapeutically silenced to reduce obesity in mice , 2020, Nature Metabolism.

[16]  Yun Zheng,et al.  A Novel Ferroptosis-related Gene Signature for Overall Survival Prediction in Patients with Hepatocellular Carcinoma , 2020, International journal of biological sciences.

[17]  F. Xue,et al.  CircularRNA-9119 protects hepatocellular carcinoma cells from apoptosis by intercepting miR-26a/JAK1/STAT3 signaling , 2020, Cell Death & Disease.

[18]  D. Green,et al.  The clearance of dead cells by efferocytosis , 2020, Nature Reviews Molecular Cell Biology.

[19]  Chao Pi,et al.  Synergistic Effects of Curcumin and 5-Fluorouracil on the Hepatocellular Carcinoma In vivo and vitro through regulating the expression of COX-2 and NF-κB , 2020, Journal of Cancer.

[20]  M. Hussein,et al.  Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities , 2020, International journal of nanomedicine.

[21]  P. Lampertico,et al.  Epidemiology and surveillance for hepatocellular carcinoma: New trends. , 2020, Journal of hepatology.

[22]  Lan Xu,et al.  miR-31 Modulates Liver Cancer HepG2 Cell Apoptosis and Invasion via ROCK1/F-Actin Pathways , 2020, OncoTargets and therapy.

[23]  Mitchell Ho,et al.  Engineered Anti‐GPC3 Immunotoxin, HN3‐ABD‐T20, Produces Regression in Mouse Liver Cancer Xenografts Through Prolonged Serum Retention , 2020, Hepatology.

[24]  B. Cowie,et al.  Modeling Progress Toward Elimination of Hepatitis B in Australia , 2019, Hepatology.

[25]  Jing Hu,et al.  Long noncoding RNA Linc01296 promotes hepatocellular carcinoma development through regulation of the miR-26a/PTEN axis , 2019, Biological chemistry.

[26]  W. Fang,et al.  Role of ALDH1A1 and HTRA2 expression in CCL2/CCR2-mediated breast cancer cell growth and invasion , 2019, Biology Open.

[27]  Dominic Grün,et al.  A Human Liver Cell Atlas reveals Heterogeneity and Epithelial Progenitors , 2019, Nature.

[28]  Yingliang Ou,et al.  miR‐186 modulates hepatocellular carcinoma cell proliferation and mobility via targeting MCRS1‐mediated Wnt/β‐catenin signaling , 2019, Journal of cellular physiology.

[29]  C. McCall,et al.  Systematic Dissection of the Metabolic-Apoptotic Interface in AML Reveals Heme Biosynthesis to Be a Regulator of Drug Sensitivity. , 2019, Cell metabolism.

[30]  Lungen Lu,et al.  Epidermal growth factor‐containing fibulin‐like extracellular matrix protein 1 (EFEMP1) suppressed the growth of hepatocellular carcinoma cells by promoting Semaphorin 3B(SEMA3B) , 2019, Cancer medicine.

[31]  Xuesi Chen,et al.  Evaluation of Polymer Nanoformulations in Hepatoma Therapy by Established Rodent Models , 2019, Theranostics.

[32]  H. Huber,et al.  Transforming Growth Factor‐β and Axl Induce CXCL5 and Neutrophil Recruitment in Hepatocellular Carcinoma , 2018, Hepatology.

[33]  Huirong Liu,et al.  Omi/HtrA2 Participates in Age-Related Autophagic Deficiency in Rat Liver , 2018, Aging and disease.

[34]  P. Lin,et al.  Long Non-Coding MALAT1 Functions as a Competing Endogenous RNA to Regulate Vimentin Expression by Sponging miR-30a-5p in Hepatocellular Carcinoma , 2018, Cellular Physiology and Biochemistry.

[35]  Ziwei Wang,et al.  miR-26a/HOXC9 Dysregulation Promotes Metastasis and Stem Cell-Like Phenotype of Gastric Cancer , 2018, Cellular Physiology and Biochemistry.

[36]  Honggang Wang,et al.  The expression of HtrA2 and its diagnostic value in patients with hepatocellular carcinoma , 2018, Medicine.

[37]  T. Hunter,et al.  The protein histidine phosphatase LHPP is a tumour suppressor , 2018, Nature.

[38]  G. Giaccone,et al.  An endogenous DNA adduct as a prognostic biomarker for hepatocarcinogenesis and its prevention by Theaphenon E in mice , 2018, Hepatology.

[39]  H. Tsuda,et al.  Ovarian serous carcinomas acquire cisplatin resistance and increased invasion through downregulation of the high-temperature-required protein A2 (HtrA2), following repeated treatment with cisplatin , 2017, Medical Oncology.

[40]  W. Fang,et al.  Chemokine Signaling Facilitates Early-Stage Breast Cancer Survival and Invasion through Fibroblast-Dependent Mechanisms , 2017, Molecular Cancer Research.

[41]  L. Ye,et al.  The long noncoding RNA HULC promotes liver cancer by increasing the expression of the HMGA2 oncogene via sequestration of the microRNA-186 , 2017, The Journal of Biological Chemistry.

[42]  Yu Zhou,et al.  Staurosporine suppresses survival of HepG2 cancer cells through Omi/HtrA2-mediated inhibition of PI3K/Akt signaling pathway , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[43]  Zhenran Wang,et al.  Upregulation of Akt/NF-κB-regulated inflammation and Akt/Bad-related apoptosis signaling pathway involved in hepatic carcinoma process: suppression by carnosic acid nanoparticle , 2016, International journal of nanomedicine.

[44]  A. Børresen-Dale,et al.  Differential expression of miRNAs in pancreatobiliary type of periampullary adenocarcinoma and its associated stroma , 2016, Molecular oncology.

[45]  H. Tsuda,et al.  High-temperature-required protein A2 as a predictive marker for response to chemotherapy and prognosis in patients with high-grade serous ovarian cancers , 2015, British Journal of Cancer.

[46]  R. Ni,et al.  The expression levels and prognostic value of high temperature required A2 (HtrA2) in NSCLC. , 2014, Pathology, research and practice.

[47]  J. Kobiela,et al.  Changes in expression of human serine protease HtrA1, HtrA2 and HtrA3 genes in benign and malignant thyroid tumors. , 2012, Oncology reports.

[48]  Xiaoping Chen,et al.  Hypoxia-inducible factor-1alpha suppressed hepatocellular carcinoma cell apoptosis through influencing on Omi/HtrA2 expression and its releasing from the mitochondrion. , 2012, Oncology research.

[49]  Hongbing Shen,et al.  A variant affecting miRNAs binding in the circadian gene Neuronal PAS domain protein 2 (NPAS2) is not associated with breast cancer risk , 2011, Breast Cancer Research and Treatment.

[50]  J. Nelson,et al.  Integrin alpha 7 interacts with high temperature requirement A2 (HtrA2) to induce prostate cancer cell death. , 2010, The American journal of pathology.

[51]  David N. Groff,et al.  Pdx1 (MODY4) regulates pancreatic beta cell susceptibility to ER stress , 2009, Proceedings of the National Academy of Sciences.

[52]  J. Meléndez-Zajgla,et al.  Participation of Omi Htra2 Serine-Protease Activity in the Apoptosis Induced by Cisplatin on SW480 Colon Cancer Cells , 2008, Journal of chemotherapy.

[53]  Fuqing Zeng,et al.  Immunohistochemical analysis of Omi/HtrA2 expression in prostate cancer and benign prostatic hyperplasia , 2006, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[54]  W. Park,et al.  Immunohistochemical analysis of Omi/HtrA2 expression in stomach cancer , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.